Nureca Ltd

₹ 321 0.36%

16 Oct - close price

About

Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.^[1]

Key Points

Business Overview:^[1]^[2]
NL is a digitally first, consumer healthcare company with presence in categories such
as home diagnostics, wellness devices, and personal fitness equipment under brands like
Dr Trust and Dr Physio. The company has 277+ Active SKUs, and 7 New Products were launched during Q1FY26

Website BSE NSE - BE

Market Cap ₹ 306 Cr.
Current Price ₹ 321
High / Low ₹ 376 / 200
Stock P/E 70.5
Book Value ₹ 189
Dividend Yield 0.00 %
ROCE 3.30 %
ROE 1.12 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company has reduced debt.
Company is almost debt free.
Promoter holding has increased by 2.59% over last quarter.

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of -7.19% over past five years.
Company has a low return on equity of -0.56% over last 3 years.
Earnings include an other income of Rs.7.35 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	21.23	31.35	22.37	16.97	20.27	31.19	26.46	31.74	34.18	37.74	39.64	35.41	40.34
	24.13	29.97	26.62	21.40	22.63	33.54	30.47	30.54	34.74	34.47	36.39	41.19	36.92
Operating Profit	-2.90	1.38	-4.25	-4.43	-2.36	-2.35	-4.01	1.20	-0.56	3.27	3.25	-5.78	3.42
OPM %	-13.66%	4.40%	-19.00%	-26.10%	-11.64%	-7.53%	-15.15%	3.78%	-1.64%	8.66%	8.20%	-16.32%	8.48%
	2.67	3.20	5.90	-1.26	5.79	3.17	1.48	1.99	2.57	2.32	2.19	1.02	1.82
Interest	0.12	0.08	0.11	0.18	0.15	0.27	0.18	0.62	0.25	0.46	0.28	0.30	0.20
Depreciation	0.58	0.59	0.59	0.60	0.66	0.62	0.54	0.52	0.53	0.54	0.50	0.45	0.61
Profit before tax	-0.93	3.91	0.95	-6.47	2.62	-0.07	-3.25	2.05	1.23	4.59	4.66	-5.51	4.43
Tax %	-23.66%	25.83%	82.11%	-35.86%	36.64%	585.71%	-13.85%	-20.00%	34.15%	21.13%	19.96%	10.71%	30.93%
	-0.71	2.89	0.17	-4.15	1.66	-0.48	-2.80	2.47	0.81	3.63	3.73	-6.09	3.07
EPS in Rs	-0.71	2.89	0.17	-4.15	1.66	-0.48	-2.80	2.47	0.81	3.63	3.91	-6.38	3.22
Raw PDF

Upcoming result date: 21 October 2026

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	62	99	213	256	111	92	110	147	153
	53	90	152	200	126	102	117	147	149
Operating Profit	9	10	62	56	-15	-10	-8	0	4
OPM %	15%	10%	29%	22%	-13%	-11%	-7%	0.1%	2.7%
	0	0	3	8	7	11	12	8	7
Interest	0	1	2	1	0	0	1	1	1
Depreciation	0	0	0	1	2	2	2	2	2
Profit before tax	9	9	62	61	-11	-3	1	5	8
Tax %	30%	26%	26%	26%	-23%	-30%	37%	58%
	6	6	46	45	-8	-2	1	2	4
EPS in Rs	623.00	640.00	46.37	44.96	-8.25	-1.79	0.85	2.18	4.38
Dividend Payout %	0%	0%	4%	7%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	%
5 Years:	-7%
3 Years:	10%
TTM:	24%

Compounded Profit Growth
10 Years:	%
5 Years:	-46%
3 Years:	30%
TTM:	176%

Stock Price CAGR
10 Years:	%
5 Years:	-29%
3 Years:	-4%
1 Year:	11%

Return on Equity
10 Years:	%
5 Years:	3%
3 Years:	-1%
Last Year:	1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.01	0.01	10	10	10	10	10	10
Reserves	8	15	153	193	185	183	184	171
	0	10	4	4	3	3	5	2
	15	9	19	12	8	10	11	13
Total Liabilities	24	34	186	219	207	205	210	196
	1	1	4	10	9	7	9	14
CWIP	0	0	0	0	0	0	0	0
Investments	0	0	0	33	59	94	1	1
	23	33	182	175	139	104	200	182
Total Assets	24	34	186	219	207	205	210	196

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0	-8	35	1	10	-3	-19	3
	-0	-0	-110	-3	-16	18	8	14
	-0	8	92	-7	-2	-1	-0	-20
Net Cash Flow	0	-0	17	-9	-8	14	-11	-2
Free Cash Flow	0	-8	34	-5	10	-4	-23	-3
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	4%	-82%	81%	35%	-96%	39%	234%	1,464%

Ratios

Consolidated / View Standalone

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	52	47	6	4	14	6	11	19
Inventory Days	123	93	135	174	167	186	214	187
Days Payable	89	33	32	13	24	31	35	20
Cash Conversion Cycle	87	107	109	165	157	161	190	186
Working Capital Days	45	85	61	109	156	176	163	145
ROCE %		57%	67%	33%	-6%	-4%	1%	3%

Insights

In beta

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Cumulative Online Customer Base
thousands

x,xxx	x,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
	x.xx	x.xx	x.xx	xx.xx	xx.xx	xx.xx
	xxx	xxx		xxx	xxx	xxx
			x.xx	x.xx	x.xx	x.xx
		xxx		xxx	xxx	xxx
	xx			xx	xx	xx
		xx			xx	xx
						xxx,xxx

Please log in to see hidden values.

Manufacturing Subsidiary (NTPL) Sales
INR Crore

Active SKUs
count

Dr Trust 360 App Users
millions

Live Distributors
count

Online Revenue Contribution
%

Live States & Union Territories
count

Manufacturing Annual Capacity
units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

30 Recently

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	63.24%	63.24%	63.24%	63.78%	64.06%	64.30%	64.33%	64.97%	64.97%	68.09%	68.09%	70.68%
	0.07%	0.07%	0.07%	0.69%	0.36%	1.07%	0.07%	0.07%	0.08%	0.28%	0.11%	0.22%
	0.00%	0.00%	0.00%	0.00%	0.04%	0.04%	0.04%	0.04%	0.04%	0.24%	0.24%	0.24%
	36.69%	36.69%	36.69%	35.53%	35.54%	34.59%	35.56%	34.92%	34.91%	31.39%	31.57%	28.85%
No. of Shareholders	49,600	45,996	43,813	41,986	41,314	39,304	38,075	37,468	35,801	34,558	33,979	31,719

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
	70.00%	70.00%	62.98%	63.24%	64.30%	68.09%	70.68%
	10.51%	12.22%	0.10%	0.07%	1.07%	0.28%	0.22%
	8.09%	5.23%	0.00%	0.00%	0.04%	0.24%	0.24%
	11.40%	12.55%	36.91%	36.69%	34.59%	31.39%	28.85%
No. of Shareholders	7,827	26,123	58,560	45,996	39,304	34,558	31,719

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Concalls

Jul 2026

Transcript

AI Summary
PPT
May 2026

Transcript

AI Summary
PPT
Jan 2026

Transcript

AI Summary
PPT
Jan 2026

Transcript

AI Summary
PPT
Oct 2025

Transcript

AI Summary
PPT
Jul 2025

Transcript

AI Summary
PPT
May 2025

Transcript

AI Summary
PPT
Jan 2025

Transcript

AI Summary
PPT
Oct 2024

Transcript

AI Summary
PPT
Aug 2024

Transcript

AI Summary
PPT
May 2024

Transcript

AI Summary
PPT
Feb 2024

Transcript

AI Summary
PPT
Nov 2023

Transcript

AI Summary
PPT
Aug 2023

Transcript

AI Summary
PPT